HSBC takeaway - part 2

Readers might recall that earlier this week HSBC was quick out of the blocks to boast how it was the "sole" financial advisor to ChemChina on its $43 billion purchase of Sygenta, sending out a release on topic in the early hours of Wednesday morning...

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Friday, 5 February 2016, 1:20 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation